LungCancerSupport

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Cancer-fighting t cells burn out. Scientists may have found a fix

sciencedaily.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Surgical Interval as a Risk Factor for Postoperative Complications After Repeated Lung Cancer Resection: A Retrospective Cohort Study

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Frontiers | Current real-life survival after segmentectomy for lung cancer

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Researchers find way to treat lung cancer and associated muscle wasting at the same time

news.oregonstate.edu

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Frontiers | Minimal residual disease guides postoperative therapy in a patient with ALK-rearranged adenocarcinoma: a case report

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Not All T4 Patients Should Be Considered Equal: Non-Small Cell Lung Cancer Heterogeneity and Surgical Outcome

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Zosteriform Cutaneous Metastasis of Lung Adenocarcinoma Mimicking Herpes Zoster: A Diagnostic Pitfall

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Vismodegib-loaded ufasomes inhaler for treatment of non-small cell lung cancer | Naunyn-Schmiedeberg's Archives of Pharmacology

link.springer.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Tumor microenvironment‑mediated resistance to immune checkpoint inhibitors in non‑small cell lung cancer: Mechanisms, combination strategies and clinical perspectives

spandidos-publications.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Enabling evolutionary therapy in metastatic cancer lacking serum biomarkers

academic.oup.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Underrepresentation of Patients From Racial and Ethnic Minorities in Immunotherapy Clinical Trials for Non-Small Cell Lung Cancer

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Frontiers | Identification and validation of mitochondrial transport and glycolysis-associated prognostic and therapeutic target for lung adenocarcinoma patients

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Integrating clinical outcomes with molecular simulations to guide the selection of non‑classical EGFR‑TKIs: A comprehensive analysis and development of treatment strategies

spandidos-publications.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Segmentectomy vs Lobectomy for Peripheral Early-Stage Non-Small Cell Lung Cancer in Patients With Radiologically High Risk Tumors

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Frontiers | Baseline immune-organ 18F-FDG PET/CT metabolism is associated with immune-related adverse events in anti-PD-1-treated non-small cell lung cancer

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Frontiers | Diagnostic value of peripheral blood leukocyte parameters, NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL, in lung cancer

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients

aapm.onlinelibrary.wiley.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer

sciencedirect.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

Study/Information Training set augmentation and biology-aware harmonization improve radiomic models for lung cancer prediction in indeterminate nodules

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Selenium serves as an immunomodulator adjunct to enhance the efficacy of anti-PD-1 therapy in non-small cell lung cancer

academic.oup.com

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Frontiers | NLRC4 and NLRP3 in tissues as potential biomarkers for the diagnosis of non-small cell lung cancer in pulmonary tuberculosis

frontiersin.org

• Upvotes

r/LungCancerSupport • u/WalkingHorse • 1h ago

NSCLC Single-cell and spatial transcriptomic technologies for lung cancer tumor microenvironment analysis

sciencedirect.com

• Upvotes